Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Progression‐free survival · locally advanced or metastatic breast cancer

PARPi‐containing regimen leads to lower progression Free Survival** compared with non‐PARPi regimen (high certainty).

1 finding from 1 review

PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer 2021 · Cochrane Headline outcomes only
HR 0.63 [0.56, 0.71]
5 studies · 1474 participants
High